Back
Apellis Pharmaceuticals, Inc. Vs. Insmed, Inc. Industry Stock Comparison
Buy
53
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$24.48
Seasonality Move:
7.92%
Sell
40
INSM
Insmed, Inc.
Last Price:
$166.55
Seasonality Move:
7.61%
Buy
53
Apellis Pharmaceuticals, Inc. (APLS)
is a Buy
Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals, Inc. [APLS] share price is $24.48. The Score for APLS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Insmed, Inc. (INSM)
is a Sell
Is Insmed, Inc. a Buy, Sell or Hold?
-
The current Insmed, Inc. [INSM] share price is $166.55. The Score for INSM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
INSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLS Stock Price Chart
What is Apellis Pharmaceuticals, Inc.'s stock price today?
-
The Apellis Pharmaceuticals, Inc. share price today is $24.48The current trend is moderately bullish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
INSM Stock Price Chart
What is Insmed, Inc.'s stock price today?
-
The Insmed, Inc. share price today is $166.55Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight selling pressure.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.87 | Buy |
| Relative Strength Index (14 RSI): | 59.19 | Buy |
| Chaikin Money Flow: | -2667078 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.03 - 24.25) | Buy |
| Bollinger Bands (100): | (21.18 - 27.04) | Buy |
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 29.93 | Sell |
| Chaikin Money Flow: | -270452 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (190.54 - 208.08) | Sell |
| Bollinger Bands (100): | (130.7 - 191.18) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.78 | Sell |
| 20-day SMA: | 22.7 | Buy |
| 50-day SMA: | 23.13 | Buy |
| 200-day SMA: | 21.91 | Buy |
| 8-day EMA: | 24.49 | Sell |
| 20-day EMA: | 23.39 | Buy |
| 50-day EMA: | 23.05 | Buy |
| 200-day EMA: | 24.27 | Buy |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 192.36 | Sell |
| 20-day SMA: | 199.79 | Sell |
| 50-day SMA: | 186.64 | Sell |
| 200-day SMA: | 121.17 | Buy |
| 8-day EMA: | 191.25 | Sell |
| 20-day EMA: | 194.86 | Sell |
| 50-day EMA: | 184.92 | Sell |
| 200-day EMA: | 135.61 | Buy |
Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.
Insmed, Inc. Earnings Growth & INSM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and an increase next year of $2.60 per share.
Apellis Pharmaceuticals, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Insmed, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||